Major increase in hidradenitis suppurativa cases anticipated

Once thought to be a rare disease and largely neglected as a focus of research, hidradenitis suppurativa (HS) is now the target of more research funding that is expected to lead to better treatments and increase the number of patients seeking care, according to Haley B. Naik, MD, of the department of dermatology at University of California, San Francisco. Find out more at www.mdedge.com.

Видео Major increase in hidradenitis suppurativa cases anticipated канала MDedge: news and insights for busy physicians